APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Labialis Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Herpes Labialis Drugs Industry Growth and Trends Forecast to 2032

27 December 2025100 pages

Choose your research edition.

Industry ResearchHerpes Labialis Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Labialis Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Herpes Labialis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Labialis Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Labialis Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Herpes Labialis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Herpes Labialis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Herpes Labialis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Labialis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Labialis Drugs include GSK, Teva, Novartis, Mylan, Livzon, Bayer, Med Shine, Hikma and Daewoong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Herpes Labialis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Herpes Labialis Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Herpes Labialis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Herpes Labialis Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Herpes Labialis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Herpes Labialis Drugs Market by Company

GSK

Teva

Novartis

Mylan

Livzon

Bayer

Med Shine

Hikma

Daewoong Pharmaceutical

Cipher

Carmex

Cadila

Blistex

Apotex

Herpes Labialis Drugs Segment by Type

Aciclovir

Docosanol

Famciclovir

Valacyclovir

Other

Herpes Labialis Drugs Segment by Application

Injection

External Use

Oral

Herpes Labialis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Labialis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Labialis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Labialis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herpes Labialis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Herpes Labialis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aciclovir Table 2. Major Company of Docosanol Table 3. Major Company of Famciclovir Table 4. Major Company of Valacyclovir Table 5. Major Company of Other Table 6. Global Herpes Labialis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 8. Global Herpes Labialis Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Herpes Labialis Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Herpes Labialis Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Herpes Labialis Drugs Sales by Type (2027-2032) & (W Units) Table 13. Global Herpes Labialis Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Herpes Labialis Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Herpes Labialis Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Herpes Labialis Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 18. North America Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 20. Europe Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 24. Latin America Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Herpes Labialis Drugs Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Herpes Labialis Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Herpes Labialis Drugs Industry Trends Table 28. Herpes Labialis Drugs Industry Drivers Table 29. Herpes Labialis Drugs Industry Opportunities and Challenges Table 30. Herpes Labialis Drugs Industry Restraints Table 31. Global Herpes Labialis Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Herpes Labialis Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Herpes Labialis Drugs Sales by Company (2021-2026) & (W Units) Table 34. Global Herpes Labialis Drugs Sales Share by Company (2021-2026) Table 35. Global Herpes Labialis Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Herpes Labialis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Herpes Labialis Drugs Major Company Production Sites and Headquarters Table 38. Global Herpes Labialis Drugs Company, Product Type & Application Table 39. Global Herpes Labialis Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Herpes Labialis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Herpes Labialis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Herpes Labialis Drugs Sales by Region (2021-2026) & (W Units) Table 44. Global Herpes Labialis Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Herpes Labialis Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Herpes Labialis Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Herpes Labialis Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Herpes Labialis Drugs Sales by Region (2027-2032) & (W Units) Table 49. Global Herpes Labialis Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Herpes Labialis Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Herpes Labialis Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Herpes Labialis Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Herpes Labialis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 55. Global Herpes Labialis Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Herpes Labialis Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Herpes Labialis Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Herpes Labialis Drugs Sales by Application (2027-2032) & (W Units) Table 60. Global Herpes Labialis Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Herpes Labialis Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Herpes Labialis Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Herpes Labialis Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 65. North America Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 67. Europe Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 71. Latin America Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Herpes Labialis Drugs Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Herpes Labialis Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. GSK Company Information Table 75. GSK Business Overview Table 76. GSK Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GSK Herpes Labialis Drugs Product Portfolio Table 78. GSK Recent Development Table 79. Teva Company Information Table 80. Teva Business Overview Table 81. Teva Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Teva Herpes Labialis Drugs Product Portfolio Table 83. Teva Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Novartis Herpes Labialis Drugs Product Portfolio Table 88. Novartis Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mylan Herpes Labialis Drugs Product Portfolio Table 93. Mylan Recent Development Table 94. Livzon Company Information Table 95. Livzon Business Overview Table 96. Livzon Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Livzon Herpes Labialis Drugs Product Portfolio Table 98. Livzon Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Bayer Herpes Labialis Drugs Product Portfolio Table 103. Bayer Recent Development Table 104. Med Shine Company Information Table 105. Med Shine Business Overview Table 106. Med Shine Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Med Shine Herpes Labialis Drugs Product Portfolio Table 108. Med Shine Recent Development Table 109. Hikma Company Information Table 110. Hikma Business Overview Table 111. Hikma Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hikma Herpes Labialis Drugs Product Portfolio Table 113. Hikma Recent Development Table 114. Daewoong Pharmaceutical Company Information Table 115. Daewoong Pharmaceutical Business Overview Table 116. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Daewoong Pharmaceutical Herpes Labialis Drugs Product Portfolio Table 118. Daewoong Pharmaceutical Recent Development Table 119. Cipher Company Information Table 120. Cipher Business Overview Table 121. Cipher Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Cipher Herpes Labialis Drugs Product Portfolio Table 123. Cipher Recent Development Table 124. Carmex Company Information Table 125. Carmex Business Overview Table 126. Carmex Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Carmex Herpes Labialis Drugs Product Portfolio Table 128. Carmex Recent Development Table 129. Cadila Company Information Table 130. Cadila Business Overview Table 131. Cadila Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Cadila Herpes Labialis Drugs Product Portfolio Table 133. Cadila Recent Development Table 134. Blistex Company Information Table 135. Blistex Business Overview Table 136. Blistex Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Blistex Herpes Labialis Drugs Product Portfolio Table 138. Blistex Recent Development Table 139. Apotex Company Information Table 140. Apotex Business Overview Table 141. Apotex Herpes Labialis Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Apotex Herpes Labialis Drugs Product Portfolio Table 143. Apotex Recent Development Table 144. North America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. North America Herpes Labialis Drugs Sales by Country (2021-2026) & (W Units) Table 146. North America Herpes Labialis Drugs Sales Market Share by Country (2021-2026) Table 147. North America Herpes Labialis Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 148. North America Herpes Labialis Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. North America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Herpes Labialis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Herpes Labialis Drugs Market Share by Country (2021-2026) Table 152. North America Herpes Labialis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Herpes Labialis Drugs Market Share Forecast by Country (2027-2032) Table 154. Europe Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Europe Herpes Labialis Drugs Sales by Country (2021-2026) & (W Units) Table 156. Europe Herpes Labialis Drugs Sales Market Share by Country (2021-2026) Table 157. Europe Herpes Labialis Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 158. Europe Herpes Labialis Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Herpes Labialis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Herpes Labialis Drugs Market Share by Country (2021-2026) Table 162. Europe Herpes Labialis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Herpes Labialis Drugs Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Herpes Labialis Drugs Sales by Country (2021-2026) & (W Units) Table 166. Asia-Pacific Herpes Labialis Drugs Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Herpes Labialis Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 168. Asia-Pacific Herpes Labialis Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Herpes Labialis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Herpes Labialis Drugs Market Share by Country (2021-2026) Table 172. Asia-Pacific Herpes Labialis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Herpes Labialis Drugs Market Share Forecast by Country (2027-2032) Table 174. Latin America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 175. Latin America Herpes Labialis Drugs Sales by Country (2021-2026) & (W Units) Table 176. Latin America Herpes Labialis Drugs Sales Market Share by Country (2021-2026) Table 177. Latin America Herpes Labialis Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 178. Latin America Herpes Labialis Drugs Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Herpes Labialis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Herpes Labialis Drugs Market Share by Country (2021-2026) Table 182. Latin America Herpes Labialis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Herpes Labialis Drugs Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Herpes Labialis Drugs Sales by Country (2021-2026) & (W Units) Table 186. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Herpes Labialis Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 188. Middle East and Africa Herpes Labialis Drugs Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Herpes Labialis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Herpes Labialis Drugs Market Share by Country (2021-2026) Table 192. Middle East and Africa Herpes Labialis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Herpes Labialis Drugs Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Herpes Labialis Drugs Distributors List Table 197. Herpes Labialis Drugs Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Herpes Labialis Drugs Image Figure 2. Global Herpes Labialis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Labialis Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Herpes Labialis Drugs Sales (2021-2032) & (W Units) Figure 5. Aciclovir Image Figure 6. Global Aciclovir Sales YoY Growth (2021-2032) & (W Units) Figure 7. Docosanol Image Figure 8. Global Docosanol Sales YoY Growth (2021-2032) & (W Units) Figure 9. Famciclovir Image Figure 10. Global Famciclovir Sales YoY Growth (2021-2032) & (W Units) Figure 11. Valacyclovir Image Figure 12. Global Valacyclovir Sales YoY Growth (2021-2032) & (W Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Herpes Labialis Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Herpes Labialis Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Herpes Labialis Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Herpes Labialis Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Herpes Labialis Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Herpes Labialis Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Herpes Labialis Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Herpes Labialis Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Herpes Labialis Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Herpes Labialis Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Herpes Labialis Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Herpes Labialis Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Herpes Labialis Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Injection Image Figure 30. Global Injection Sales YoY Growth (2021-2032) & (W Units) Figure 31. External Use Image Figure 32. Global External Use Sales YoY Growth (2021-2032) & (W Units) Figure 33. Oral Image Figure 34. Global Oral Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Herpes Labialis Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Herpes Labialis Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Herpes Labialis Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Herpes Labialis Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Herpes Labialis Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Herpes Labialis Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Herpes Labialis Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Herpes Labialis Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Herpes Labialis Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Herpes Labialis Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Herpes Labialis Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Herpes Labialis Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Herpes Labialis Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Herpes Labialis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Herpes Labialis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Herpes Labialis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Herpes Labialis Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Herpes Labialis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Herpes Labialis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Herpes Labialis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Herpes Labialis Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Herpes Labialis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Herpes Labialis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Herpes Labialis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Herpes Labialis Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Herpes Labialis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Herpes Labialis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Herpes Labialis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Herpes Labialis Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Herpes Labialis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Herpes Labialis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Herpes Labialis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Herpes Labialis Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Herpes Labialis Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Aciclovir
  • Docosanol
  • Famciclovir
  • Valacyclovir
  • Other
Applications
  • Injection
  • External Use
  • Oral
Companies covered
  • GSK
  • Teva
  • Novartis
  • Mylan
  • Livzon
  • Bayer
  • Med Shine
  • Hikma
  • Daewoong Pharmaceutical
  • Cipher
  • Carmex
  • Cadila
  • Blistex
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Labialis Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Herpes Labialis Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Herpes Labialis Drugs Market by Type
  6. 1.3.1 Aciclovir
  7. 1.3.2 Docosanol
  8. 1.3.3 Famciclovir
  9. 1.3.4 Valacyclovir
  10. 1.3.5 Other
  11. 1.4 Global Herpes Labialis Drugs Market Size by Type
  12. 1.4.1 Global Herpes Labialis Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Herpes Labialis Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Herpes Labialis Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Herpes Labialis Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Herpes Labialis Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Herpes Labialis Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Herpes Labialis Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Herpes Labialis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Herpes Labialis Drugs Industry Trends
  2. 2.2 Herpes Labialis Drugs Industry Drivers
  3. 2.3 Herpes Labialis Drugs Industry Opportunities and Challenges
  4. 2.4 Herpes Labialis Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Herpes Labialis Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Herpes Labialis Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Herpes Labialis Drugs Price (2021-2026)
  4. 3.4 Global Herpes Labialis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Labialis Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Herpes Labialis Drugs Company, Product Type & Application
  7. 3.7 Global Herpes Labialis Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Labialis Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Labialis Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herpes Labialis Drugs Tier 1, Tier 2, and Tier 3
4 Herpes Labialis Drugs Regional Status and Outlook
  1. 4.1 Global Herpes Labialis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Herpes Labialis Drugs Historic Market Size by Region
  3. 4.2.1 Global Herpes Labialis Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Herpes Labialis Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Herpes Labialis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Herpes Labialis Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Herpes Labialis Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Herpes Labialis Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Herpes Labialis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Herpes Labialis Drugs by Application
  1. 5.1 Herpes Labialis Drugs Market by Application
  2. 5.1.1 Injection
  3. 5.1.2 External Use
  4. 5.1.3 Oral
  5. 5.2 Global Herpes Labialis Drugs Market Size by Application
  6. 5.2.1 Global Herpes Labialis Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Herpes Labialis Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Herpes Labialis Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Herpes Labialis Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Herpes Labialis Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Herpes Labialis Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Herpes Labialis Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Herpes Labialis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Herpes Labialis Drugs Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Herpes Labialis Drugs Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Herpes Labialis Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Herpes Labialis Drugs Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Livzon
  26. 6.5.1 Livzon Company Information
  27. 6.5.2 Livzon Business Overview
  28. 6.5.3 Livzon Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Livzon Herpes Labialis Drugs Product Portfolio
  30. 6.5.5 Livzon Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Herpes Labialis Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Med Shine
  38. 6.7.1 Med Shine Company Information
  39. 6.7.2 Med Shine Business Overview
  40. 6.7.3 Med Shine Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Med Shine Herpes Labialis Drugs Product Portfolio
  42. 6.7.5 Med Shine Recent Developments
  43. 6.8 Hikma
  44. 6.8.1 Hikma Company Information
  45. 6.8.2 Hikma Business Overview
  46. 6.8.3 Hikma Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hikma Herpes Labialis Drugs Product Portfolio
  48. 6.8.5 Hikma Recent Developments
  49. 6.9 Daewoong Pharmaceutical
  50. 6.9.1 Daewoong Pharmaceutical Company Information
  51. 6.9.2 Daewoong Pharmaceutical Business Overview
  52. 6.9.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Daewoong Pharmaceutical Herpes Labialis Drugs Product Portfolio
  54. 6.9.5 Daewoong Pharmaceutical Recent Developments
  55. 6.10 Cipher
  56. 6.10.1 Cipher Company Information
  57. 6.10.2 Cipher Business Overview
  58. 6.10.3 Cipher Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cipher Herpes Labialis Drugs Product Portfolio
  60. 6.10.5 Cipher Recent Developments
  61. 6.11 Carmex
  62. 6.11.1 Carmex Company Information
  63. 6.11.2 Carmex Business Overview
  64. 6.11.3 Carmex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Carmex Herpes Labialis Drugs Product Portfolio
  66. 6.11.5 Carmex Recent Developments
  67. 6.12 Cadila
  68. 6.12.1 Cadila Company Information
  69. 6.12.2 Cadila Business Overview
  70. 6.12.3 Cadila Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cadila Herpes Labialis Drugs Product Portfolio
  72. 6.12.5 Cadila Recent Developments
  73. 6.13 Blistex
  74. 6.13.1 Blistex Company Information
  75. 6.13.2 Blistex Business Overview
  76. 6.13.3 Blistex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Blistex Herpes Labialis Drugs Product Portfolio
  78. 6.13.5 Blistex Recent Developments
  79. 6.14 Apotex
  80. 6.14.1 Apotex Company Information
  81. 6.14.2 Apotex Business Overview
  82. 6.14.3 Apotex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Apotex Herpes Labialis Drugs Product Portfolio
  84. 6.14.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Herpes Labialis Drugs Sales by Country
  2. 7.1.1 North America Herpes Labialis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Herpes Labialis Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Herpes Labialis Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Herpes Labialis Drugs Market Size by Country
  6. 7.2.1 North America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Herpes Labialis Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Herpes Labialis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Herpes Labialis Drugs Sales by Country
  2. 8.1.1 Europe Herpes Labialis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Herpes Labialis Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Herpes Labialis Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Herpes Labialis Drugs Market Size by Country
  6. 8.2.1 Europe Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Herpes Labialis Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Herpes Labialis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Herpes Labialis Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Herpes Labialis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Herpes Labialis Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Herpes Labialis Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Herpes Labialis Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Herpes Labialis Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Herpes Labialis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Herpes Labialis Drugs Sales by Country
  2. 10.1.1 South America Herpes Labialis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Herpes Labialis Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Herpes Labialis Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Herpes Labialis Drugs Market Size by Country
  6. 10.2.1 South America Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Herpes Labialis Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Herpes Labialis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Herpes Labialis Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Herpes Labialis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Herpes Labialis Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Herpes Labialis Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Herpes Labialis Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Herpes Labialis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Herpes Labialis Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Herpes Labialis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Herpes Labialis Drugs Value Chain Analysis
  2. 12.1.1 Herpes Labialis Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Herpes Labialis Drugs Production Mode & Process
  7. 12.2 Herpes Labialis Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Herpes Labialis Drugs Distributors
  10. 12.2.3 Herpes Labialis Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst